Fundz

Genesystem to buy Odecaribe via individual

PRIVATENov 18, 2026

Acquiring Company

Genesystem

Acquired Company

Odecaribe

DaejeonSouth KoreaBiotechnologyHealth CareHealth CareFashionBeautyLifestyle

Description

Genesystem decided on Nov. 16, 2026 to acquire the Odecaribe business from Kang Ji-wan, who will receive the rights and assets from Maxism, Rotra, and Kertier. The deal is valued at about 3.3 billion won and will be paid in treasury shares and perpetual convertible bonds. The structure has drawn criticism over its transparency.

Quick answer

Genesystem is acquiring Odecaribe, announced November 18, 2026. Genesystem is based in Daejeon, Daejeon, South Korea.

How much did Genesystem pay for Odecaribe?
The deal value was not disclosed.
What does Genesystem do?
Genesystem is a molecular diagnostics company listed on KOSDAQ.
Where are Genesystem and Odecaribe based?
Genesystem is based in Daejeon, Daejeon, South Korea. Odecaribe is based in South Korea.

Source: Fundz verified event record.

Other recent acquisitions in Fashion and Beauty

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Genesystem, and when

When Genesystem changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Genesystem raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Genesystem, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Genesystem. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Genesystem

Location

Daejeon, Daejeon, South Korea

About

Genesystem is a molecular diagnostics company listed on KOSDAQ. The company's revenue has declined sharply since the end of the COVID-19 pandemic. It is pursuing acquisitions to lift revenue and maintain its listing.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Genesystem makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Genesystem's next move

Learn about Strategic plan

Frequently asked

Who acquired Odecaribe?

Odecaribe was acquired by Genesystem, based in Daejeon. The deal was reported on November 18, 2026. Genesystem is a molecular diagnostics company listed on KOSDAQ. The company's revenue has declined sharply since the end of the COVID-19 pandemic. It is pursuing acquisitions to lift revenue and maintain its listing. Genesystem is privately held and operates in Biotechnology.

When did Genesystem acquire Odecaribe?

Genesystem's acquisition of Odecaribe was reported on November 18, 2026. Genesystem decided on Nov. 16, 2026 to acquire the Odecaribe business from Kang Ji-wan, who will receive the rights and assets from Maxism, Rotra, and Kertier. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Odecaribe do?

Odecaribe is a shampoo and hair care brand. The business rights and assets are held by three corporations: Maxism, Rotra, and Kertier. The brand was run with an individual holding its trademark. It is privately held, operating in Health Care, and is based in South Korea.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.